Programmed Death Ligand 1 (PD-L1) Expression in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)

被引：0

作者：

D'Arcangelo, M. ^{[1
]}

Puccetti, M. ^{[2
]}

Bravaccini, S. ^{[3
]}

D'Incecco, A. ^{[4
]}

Ligorio, C. ^{[5
]}

Terracciano, L. ^{[6
]}

Damiani, S. ^{[5
]}

Ravaioli, S. ^{[3
]}

Tumedei, M. M. ^{[3
]}

Bennati, C. ^{[1
]}

Minuti, G. ^{[1
]}

Vecchiarelli, S. ^{[1
]}

Landi, L. ^{[1
]}

Incarbone, M. ^{[7
]}

Milesi, M. ^{[7
]}

Cappuzzo, F. ^{[1
]}

机构：

[1] Ausl Romagna, Oncol Hematol, Ravenna, Italy

[2] Ausl Romagna, Pathol, Ravenna, Italy

[3] IRST, Lab Biosci, Meldola, Italy

[4] Univ Hosp Siena, Ctr Immunooncol, Siena, Italy

[5] Univ Bologna, Bologna, Italy

[6] Univ Hosp Basel, Basel, Switzerland

[7] Multimedica, Milan, Italy

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期

关键词：

NSCLC; Tumor grade; PD-L1;

D O I：

10.1016/j.jtho.2017.09.1937

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PUB074

引用

页码：S2390 / S2390

页数：1

共 50 条

[1] Circulating Programmed Death Ligand-1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
Vecchiarelli, S.
D'Incecco, A.
Minuti, G.
Gallo, M.
De Luca, A.
Landi, L.
Bennati, C.
Spreafico, M.
D'Arcangelo, M.
Attilia, L.
Mazza, V.
Normanno, N.
Cappuzzo, F.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2389 - S2389
[2] Circulating programmed death ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC)
Vecchiarelli, S.
D'Incecco, A.
Gallo, M.
De Luca, A.
Minuti, G.
Landi, L.
Bennati, C.
Spreafico, M.
D'Arcangelo, M.
Attilia, L.
Mazza, V.
Normanno, N.
Cappuzzo, F.
ANNALS OF ONCOLOGY, 2017, 28
[3] Programmed death ligand-1 (PD-L1) heterogeneity in non-small cell lung cancer (NSCLC)
McLaughlin, Joseph
Schalper, Kurt A.
Carvajal-Hausdorf, Daniel E.
Pelekanou, Vasiliki
Velcheti, Vamsidhar
Haack, Herbert
Silver, Matthew R.
Herbst, Roy
LoRusso, Patricia
Rimm, David L.
CANCER RESEARCH, 2015, 75
[4] Spatiotemporal Effects on Programmed Death Ligand 1 (PD-L1) Expression and Immunophenotype of Non-Small Cell Lung Cancer (NSCLC)
Kowanetz, Marcin
Koeppen, Hartmut
Boe, Marigold
Chaft, Jamie E.
Rudin, Charles M.
Zou, Wei
Nickles, Dorothee
Desai, Rupal
Nakamura, Rin
Sandler, Alan
Amler, Lukas
Hegde, Priti
Rizvi, Naiyer A.
Hellmann, Matthew D.
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S199 - S199
[5] Programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer (NSCLC), results of a single institution
Slezak, A.
Toth, E.
VIRCHOWS ARCHIV, 2018, 473 : S112 - S112
[6] Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis
Babayeva, Sabina
Dyatlov, Arteni
Pallavi, Ranjita
Fanucchi, Michael
Puccio, Carmelo
Lafaro, Rocco
Shakil, Fouzia
Fallon, John T.
Zhong, Minghao
MODERN PATHOLOGY, 2016, 29 : 467A - 467A
[7] Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis
Babayeva, Sabina
Dyatlov, Artem
Pallavi, Ranjita
Fanucchi, Michael
Puccio, Carmelo
Lafaro, Rocco
Shakil, Fouzia
Fallon, John T.
Zhong, Minghao
LABORATORY INVESTIGATION, 2016, 96 : 467A - 467A
[8] Programmed death-ligand (PD-L1) expression and tissue heterogeneity in advanced non-small cell lung cancer (NSCLC)
Decatris, Marios
Hayes, Mark
Du Rand, Ingrid
Ryan, Philip
Phillips, Aled
El-Batrawy, Sherouk
Homewood, Renate
Thomas, Joy
Bowden, Caitlin
Taniere, Phillipe
LUNG CANCER, 2021, 156 : S29 - S30
[9] Expression analysis of programmed cell death 1 ligand 1 (PD-L1) in patients with non-small cell lung cancer
Peng, Nanqiu
Qin, Liang
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 15 (01): : 1 - 5
[10] Programmed death ligand 1 (PD-L1) expression status as prognostic factor in early stage non-small cell lung cancer (NSCLC)
D'Arcangelo, M.
Puccetti, M.
Bravaccini, S.
D'Incecco, A.
Ligorio, C.
Terracciano, L.
Damiani, S.
Bennati, C.
Minuti, G.
Vecchiarelli, S.
Landi, L.
Incarbone, M.
Milesi, M.
Ravaioli, S.
Tumedei, M. M.
Rossi, E.
Cappuzzo, F.
ANNALS OF ONCOLOGY, 2017, 28

← 1 2 3 4 5 →